Literature DB >> 9504754

High level expression of the capsid protein of hepatitis E virus in diverse eukaryotic cells using the Semliki Forest virus replicon.

J Torresi1, J Meanger, P Lambert, F Li, S A Locarnini, D A Anderson.   

Abstract

The capsid protein of hepatitis E virus (HEV) is encoded by open reading frame 2 (ORF 2) and exhibits variable processing when expressed in insect and COS cells, but nothing is known of its processing in cells relevant to its replication. The full-length ORF 2 protein was expressed at high levels in mammalian cells by insertion of ORF 2 in the Semliki Forest virus (SFV) replicon to generate rSFV/HEV ORF 2K. Expression of the capsid protein was detected readily by metabolic labelling and indirect immunofluorescence in BHK-21 cells transfected with RNA transcripts derived from rSFV/HEV ORF 2K. ORF 2 protein was also expressed at high levels in cells of diverse origin, including liver-derived cell lines Huh7 and HepG2, following infection with recombinant virus derived from cotransfection of BHK-21 cells with the rSFV/HEV ORF 2K and helper SFV replicon RNAs. The addition of hypertonic KCl during metabolic labelling reduced the level of host cell protein synthesis and enhanced the detection of intermediates in ORF 2 protein processing. The wide host range and high level expression directed by SFV replicon particles has particular utility in the analysis of cell-specific factors in the protein processing and assembly of non-cultivable viruses such as HEV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9504754     DOI: 10.1016/s0166-0934(97)00142-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Virus-specific mRNA capping enzyme encoded by hepatitis E virus.

Authors:  J Magden; N Takeda; T Li; P Auvinen; T Ahola; T Miyamura; A Merits; L Kääriäinen
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.

Authors:  Judith Graff; Yi-Hua Zhou; Udana Torian; Hanh Nguyen; Marisa St Claire; Claro Yu; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 5.  Molecular biology and replication of hepatitis E virus.

Authors:  Dianjun Cao; Xiang-Jin Meng
Journal:  Emerg Microbes Infect       Date:  2012-08-22       Impact factor: 7.163

6.  A C-Terminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid (ORF2) Protein.

Authors:  Li Xiaofang; Mohammad Zafrullah; Faizan Ahmad; Shahid Jameel
Journal:  J Biomed Biotechnol       Date:  2001

7.  Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope.

Authors:  Ying Qi; Feng Zhang; Li Zhang; Tim J Harrison; Weijin Huang; Chenyan Zhao; Wei Kong; Chunlai Jiang; Youchun Wang
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

Review 8.  Life cycle and morphogenesis of the hepatitis E virus.

Authors:  Kiyoshi Himmelsbach; Daniela Bender; Eberhard Hildt
Journal:  Emerg Microbes Infect       Date:  2018-11-29       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.